Spots Global Cancer Trial Database for dendritic cell vaccine
Every month we try and update this database with for dendritic cell vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dendritic Cell Vaccine for Head and Neck Cancer | NCT00492947 | Squamous Cell C... | dendritic cell ... | 18 Years - | University of Maryland, Baltimore | |
| Vaccine Therapy in Curative Resected Prostate Cancer Patients | NCT01197625 | Prostate Cancer | Dendritic cell ... | 18 Years - 75 Years | Oslo University Hospital | |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 | NCT02362464 | Prostatic Neopl... Neoplasms of Pr... Prostate Cancer Cancer Of Prost... Stage D0 Prosta... | Multi-epitope (... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Neoantigen Derived DCs as Cancer Treatment | NCT05767684 | Refractory Tumo... Solid Tumor | Dendritic Cell ... Lenvatinib Nivolumab | 20 Years - | National Health Research Institutes, Taiwan | |
| Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma | NCT02010606 | Glioblastoma Glioblastoma Mu... Glioma Astrocytoma Brain Tumor | Dendritic cell ... Dendritic cell ... | 18 Years - | Cedars-Sinai Medical Center | |
| Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma | NCT02010606 | Glioblastoma Glioblastoma Mu... Glioma Astrocytoma Brain Tumor | Dendritic cell ... Dendritic cell ... | 18 Years - | Cedars-Sinai Medical Center | |
| Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian Cancer | NCT05270720 | Recurrent Ovari... | dendritic cell | 18 Years - 75 Years | West China Second University Hospital | |
| Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme | NCT00323115 | Glioblastoma Mu... | Autologous Dend... Temozolomide Radiotherapy Dendritic Cell ... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) | NCT05533203 | Metastatic Cast... | Prodencel; an a... | 18 Years - | Shanghai Humantech Biotechnology Co. Ltd | |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma | NCT01808820 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 13 Years - 99 Years | University of Miami | |
| PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma | NCT05714306 | Ovarian Carcino... | PEP-DC1 OC-DC PEP-DC2 Low dose cyclop... | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients | NCT00576446 | Malignant Gliom... | Dendritic cell ... | 18 Years - | Cedars-Sinai Medical Center | |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma | NCT01808820 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 13 Years - 99 Years | University of Miami | |
| Vaccine Therapy in Curative Resected Prostate Cancer Patients | NCT01197625 | Prostate Cancer | Dendritic cell ... | 18 Years - 75 Years | Oslo University Hospital | |
| PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma | NCT05714306 | Ovarian Carcino... | PEP-DC1 OC-DC PEP-DC2 Low dose cyclop... | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer | NCT04487756 | Extensive-stage... | Atezolizumab 12... ADC Vaccine Carboplatin | 18 Years - | Instituto Oncológico Dr Rosell | |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood | NCT00923910 | Leukemia, Acute... Leukemia, Acute... Leukemia, Chron... Myelodysplastic... Non-Hodgkin's L... | WT1 Peptide-Pul... Donor Lymphocyt... IL-4 KLH WT1 Peptides Endotoxin Diphenhydramine Acetaminophen | 1 Year - 74 Years | National Institutes of Health Clinical Center (CC) | |
| Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy | NCT00700167 | Melanoma | dendritic cell ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients | NCT00576446 | Malignant Gliom... | Dendritic cell ... | 18 Years - | Cedars-Sinai Medical Center | |
| Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer | NCT02548169 | Pancreatic Canc... | DC Vaccine + St... | 18 Years - | Baylor Research Institute | |
| A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC | NCT05317325 | Esophageal Squa... | OCDC vaccine; N... | 18 Years - 80 Years | Sichuan University | |
| A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma | NCT02049489 | Glioblastoma Mu... | ICT-121 DC vacc... | 18 Years - | Precision Life Sciences Group | |
| Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer | NCT02548169 | Pancreatic Canc... | DC Vaccine + St... | 18 Years - | Baylor Research Institute | |
| Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) | NCT05533203 | Metastatic Cast... | Prodencel; an a... | 18 Years - | Shanghai Humantech Biotechnology Co. Ltd | |
| Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors | NCT01902771 | Glioma Brain Cancer Brain Tumor Glioblastoma Mu... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 1 Year - 29 Years | University of Miami | |
| A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC | NCT05317325 | Esophageal Squa... | OCDC vaccine; N... | 18 Years - 80 Years | Sichuan University | |
| DC Vaccine in Colorectal Cancer | NCT03730948 | Colorectal Canc... | DC vaccine | 18 Years - | University of Pennsylvania | |
| HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer | NCT03387553 | Breast Cancer Breast Cancer F... Breast Cancer, ... Invasive Breast... HER2-positive B... HER2 Positive B... Stage II Breast... Stage III Breas... | Dendritic Cell ... Neoadjuvant Che... Curative Surger... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors | NCT01902771 | Glioma Brain Cancer Brain Tumor Glioblastoma Mu... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 1 Year - 29 Years | University of Miami | |
| Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy | NCT00700167 | Melanoma | dendritic cell ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer | NCT03371485 | Advanced Non-sm... | AST-VAC2 | 18 Years - | Cancer Research UK | |
| DC Vaccine in Colorectal Cancer | NCT03730948 | Colorectal Canc... | DC vaccine | 18 Years - | University of Pennsylvania | |
| A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) | NCT05809752 | Leptomeningeal ... Triple Negative... HER2-positive B... | Dendritic Cell ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma | NCT02049489 | Glioblastoma Mu... | ICT-121 DC vacc... | 18 Years - | Precision Life Sciences Group | |
| T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma | NCT01946373 | Melanoma | Cyclophosphamid... Fludarabine T cells Interleukin-2 Dendritic cell ... | 18 Years - 74 Years | Karolinska University Hospital | |
| Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy | NCT00700167 | Melanoma | dendritic cell ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Dendritic Cell Vaccine for Head and Neck Cancer | NCT00492947 | Squamous Cell C... | dendritic cell ... | 18 Years - | University of Maryland, Baltimore | |
| Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer | NCT02362451 | Prostatic Neopl... Prostate Cancer | Autologus elutr... Multi-epitope (... | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
